KI
KIDZW
Classover Holdings, Inc.
$0.0123
0.00%
$109.6K
No data for this timeframe.
Vol
Market Cap$109.6K
Cap SizeNano Cap
Inst. Holders1 funds
Inst. Value$92.00
SEC Reports4
Recent Activity
May 14, 2026
SEC
Classover Holdings filed a 424B5 prospectus supplement for an at-the-market (ATM) offering of up to $9,115,000 of Class
424B5 — Impact 8/10
May 13, 2026
SEC
Classover Holdings' $200M universal shelf registration (S-3, File No. 333-295491) became effective on May 12, 2026. This
EFFECT — Impact 8/10
May 1, 2026
SEC
Classover Holdings filed a $200M universal shelf registration statement to offer shares of common stock, preferred stock
S-3 — Impact 8/10
Latest Reports
BEARISH
424B5
8/10
Classover Holdings filed a 424B5 prospectus supplement for an at-the-market (ATM) offering of up to $9,115,000 of Class
May 14, 2026
BEARISH
EFFECT
8/10
Classover Holdings' $200M universal shelf registration (S-3, File No. 333-295491) became effective on May 12, 2026. This
May 13, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| UBS Group AG | $92.00 | — |
1 institutional holders with $92.00 total value (1,150 shares) as of 2025-Q3. Top holders: UBS.
Top Institutional Holders — 2025-Q3
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | UBS Group AG | 1,150 | $92.00 | 100.0% | — |
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
4 SEC filing reports analyzed. Sentiment: 0 bullish, 3 bearish, 0 mixed, 1 neutral. Avg impact: 7.0/10.
BEARISH
424B5
8/10
Classover Holdings filed a 424B5 prospectus supplement for an at-the-market (ATM) offering of up to
May 14, 2026
BEARISH
EFFECT
8/10
Classover Holdings' $200M universal shelf registration (S-3, File No. 333-295491) became effective o
May 13, 2026
BEARISH
S-3
8/10
Classover Holdings filed a $200M universal shelf registration statement to offer shares of common st
May 1, 2026
NEUTRAL
EFFECT
4/10
Classover Holdings, Inc. has three separate registration statements (File Nos. 333-290710, 333-28704
Apr 23, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.